Last reviewed · How we verify
NCT06650176: MetrikaMind
METRIKAMIND - Development of a Digital Mental Health Ecosystem for Workplace Environments
trial testing Lifestyle Management in Depression Disorders in 400 participants. Not yet recruiting.
30 April 2026
Quick facts
| Lead sponsor | David Gallardo-Pujol |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 30 September 2025 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Lifestyle Management — full drug profile →
Conditions studied
- Depression Disorders — all drugs for Depression Disorders →
- Anxiety — all drugs for Anxiety →
Sponsor
David Gallardo-Pujol
Who can join
Adults 18 to 70, any sex, with Depression Disorders or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to develop and validate a digital ecosystem designed to assess and manage mental health in workplace environments. The primary purpose is to understand how digital tools can contribute to better mental health management and to gauge their effectiveness in a typical work setting. The study also aims to enhance the prediction of mental health outcomes and the course of mental health conditions through more accurate assessments. The main questions it aims to answer are: 1. How do digital assessments improve the detection and management of mental health issues like depression and anxiety in the workplace? 2. Can a digital ecosystem effectively reduce the overall cost and impact of mental health issues on productivity and employee well-being? 3. How effective are bifactor models in detecting and mitigating the impact of faking in self-reported mental health assessments in occupational settings? Participants will: 1. Engage with the Metrikamind platform to complete periodic mental health assessments. 2. Provide feedback on their experience and any changes in their mental health status, with particular attention to the accuracy and honesty of self-reported data facilitated by the implementation of bifactor models. 3. Participate in follow-up surveys to gauge long-term effects of using the digital tools on their mental health and workplace productivity. This study involves adult participants currently employed in various sectors undergoing a sick leave, who will use the Metrikamind platform over a six-month period. The research aims to collect data on the usability and effectiveness of the platform, analyzing changes in participants\' mental health through their interaction with the digital tools provided. By incorporating advanced psychometric techniques like bifactor models, the study seeks to enhance the reliability of data and improve the prediction of mental health outcomes, providing a solid foundation for potential wider application in corporate health strategies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06650176
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lifestyle Management
Trials testing the same drug.
- NCT07527559 — Fuzzle System for Appetite Control and Weight Management · NA · not yet recruiting
- NCT07335224 — Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture · NA · recruiting
- NCT06705868 — Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease. · NA · not yet recruiting
- NCT07160972 — AI-Based Lifestyle Guidance Study · NA · completed
- NCT07160985 — AI-Assisted Blood Glucose Management Study · NA · completed
Other recruiting trials for Depression Disorders
Currently open trials in the same condition.
- NCT06793397 — A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
- NCT07082998 — Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression · NA · recruiting
- NCT07107906 — Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Lone · NA · recruiting
- NCT06923995 — Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06650176 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by David Gallardo-Pujol
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06650176.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing